No Data
No Data
Shanghai Kinetic Medical (300326.SZ): Annual equity distribution of 10 shares, 0.6 yuan per share for 2023. Ex-dividend date is July 16th.
On July 8th, Gelunhui reported that Shanghai Kinetic Medical (300326.SZ) announced the equity distribution plan for the year 2023: based on the total share capital of 717,012,682 shares excluding the repurchased 13,651 shares, the company will distribute 0.6 yuan per 10 shares to all shareholders. The equity distribution record date is July 15, 2024, and the ex-dividend date is July 16, 2024.
Shanghai Kinetic Medical (300326.SZ): Currently there is no business related to intelligent manufacturing robots or organizational engineering.
On June 26th, Gelunhui, an investor, asked Shanghai Kinetic Medical (300326.SZ) on the investor interaction platform, "What involvement and accumulation does the company have in intelligent manufacturing robots and organizational engineering?" The company replied that it currently does not have business in intelligent manufacturing robots and organizational engineering.
Kelly Thai (300326.SZ): Net profit of 10.87.65 million yuan in the first quarter decreased by 85.48% year on year
On April 23, Ge Longhui (300326.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 246 million yuan, down 16.37% year on year; net profit attributable to shareholders of listed companies was 10.8765 million yuan, down 85.48% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 8.316 million yuan, down 82.13% year on year; basic earnings per share were 0.0152 yuan.
Kelly Thai (300326.SZ) announced its 2023 annual results, turning a loss into a profit of 113 million yuan
Kellitai (300326.SZ) released its 2023 annual report. The company's revenue was 956 million yuan,...
Kellitai (300326.SZ): Holding company Jienuo Medical plans to introduce employee shareholding platform
Kellitai (300326.SZ) announced that in order to further mobilize the subsidiary Jienuo Medical Management Group Co., Ltd. (“Jie...
Kellitai (300326.SZ): The subsidiary's import registration certificate for disposable bipolar radiofrequency surgical electrode kit products was approved
On March 29, Gelonghui (300326.SZ) announced that its wholly-owned subsidiary Elliquence, LLC recently obtained a Class II “Medical Device Registration Certificate” for the import of disposable bipolar radiofrequency surgical electrode sets issued by the China Drug Administration. The product has been reviewed, complies with medical device market entry requirements, and registration is permitted. It is valid until March 7, 2019. The disposable bipolar radiofrequency surgical electrode kit consists of a bipolar radiofrequency surgical electrode, a depth control valve, a guide needle, a straight working cannula, an oblique working cannula, a conical expander, and a ring drill. Product and our high-frequency hand
No Data